These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10999492)
1. Hormone replacement therapy should not be used as secondary prevention of coronary heart disease. Barbour MM Pharmacotherapy; 2000 Sep; 20(9):1021-7. PubMed ID: 10999492 [No Abstract] [Full Text] [Related]
2. Hormone replacement therapy should be administered as secondary prevention of coronary artery disease. Spencer AP Pharmacotherapy; 2000 Sep; 20(9):1028-33. PubMed ID: 10999493 [TBL] [Abstract][Full Text] [Related]
3. What pharmacists need to know about the women's health initiative estrogen plus progestin trial. Saseen JJ; Hansen LB Am J Health Syst Pharm; 2003 Feb; 60(3):281-4. PubMed ID: 12613239 [No Abstract] [Full Text] [Related]
12. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture? Groh KW; Stevermer JJ J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004 [No Abstract] [Full Text] [Related]
13. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N; JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862 [TBL] [Abstract][Full Text] [Related]
14. Are less than standard doses of hormone replacement therapy (HRT) effective for the treatment of hot flushes? Andy C J Fam Pract; 2001 Sep; 50(9):743. PubMed ID: 11674902 [No Abstract] [Full Text] [Related]
16. Consortium for the Assessment of Research on Progestins and Estrogens (CARPE) Fort Worth, Texas August 1-3, 2003. Simpkins JW; Singh M J Womens Health (Larchmt); 2004 Dec; 13(10):1165-8. PubMed ID: 15650349 [No Abstract] [Full Text] [Related]
17. Coronary heart disease in women, randomized clinical trials, HERS and RUTH. Barrett-Connor E; Wenger NK; Grady D; Mosca L; Collins P; Kornitzer M; Cox DA; Moscarelli E; Anderson PW Maturitas; 1998 Nov; 31(1):1-7. PubMed ID: 10091198 [No Abstract] [Full Text] [Related]
18. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease. Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210 [TBL] [Abstract][Full Text] [Related]